EMFAT
ASMB icon

Emerald Mutual Fund Advisers Trust’s Assembly Biosciences ASMB Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,385
Closed -$5.01M – 239
2020
Q3 		$5.01M Sell
25,385
-3,304
-12% -$832K 0.22% 104
2020
Q2 		$8.03M Buy
28,689
+1,839
+7% +$429K 0.38% 94
2020
Q1 		$4.78M Buy
26,850
+13,405
+100% +$2.87M 0.3% 102
2019
Q4 		$3.3M Sell
13,445
-20,950
-61% -$3.86M 0.13% 155
2019
Q3 		$4.06M Sell
34,395
-450
-1% -$68.1K 0.18% 141
2019
Q2 		$5.64M Hold
34,845
– – 0.22% 130
2019
Q1 		$8.23M Buy
34,845
+4,102
+13% +$1.04M 0.33% 110
2018
Q4 		$8.35M Hold
30,743
– – 0.39% 92
2018
Q3 		$13.7M Buy
30,743
+13,818
+82% +$6.47M 0.46% 86
2018
Q2 		$7.96M Buy
16,925
+7,696
+83% +$4.07M 0.29% 130
2018
Q1 		$5.44M Sell
9,229
-3,586
-28% -$2.22M 0.21% 153
2017
Q4 		$6.96M Buy
+12,815
New +$5.8M 0.28% 124

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ASMB Position: Q4 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 25,385 shares — an estimated $5.01M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ASMB in Q4 2017 and held it in 12 quarters. The position peaked at $13.7M in Q3 2018. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 25,385 Assembly Biosciences shares in Q4 2020, an estimated $5.01M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Assembly Biosciences in Q4 2017 and held it in 12 quarters.
  • Emerald Mutual Fund Advisers Trust's Assembly Biosciences position peaked at $13.7M in Q3 2018.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2020, filed 29 Jan 2021.